Drug curettage can treat anovulatory functional uterine bleeding

Anovulatory functional uterine bleeding refers to irregular uterine bleeding caused by neuroendocrine system dysfunction. It is more common in adolescence and menopause and requires timely treatment. Drug curettage can treat anovulatory functional uterine bleeding.

Method of curettage and dilatation for the treatment of functional uterine bleeding

Medical curettage is for patients with anovulatory functional uterine bleeding who lack progesterone in their bodies, causing pathological physiological changes in the uterus. Treatment method: patients receive intramuscular injections of progesterone, 20 mg per day, for 3 days until the endometrium changes to the secretory phase, and then stop taking the drug, causing an artificial decrease in blood progesterone levels.

Withdrawal bleeding may occur during treatment

When curettage is used to treat functional uterine bleeding, the endometrium is regularly shed and bleeding occurs, which is called "withdrawal bleeding". This type of bleeding is similar to the amount of menstrual bleeding and lasts for about 7 days. Sometimes the amount is large and this is inevitable. Before using progesterone, the patient must be informed that the hemostatic effect will only appear after the withdrawal bleeding stops.

Ways to reduce withdrawal bleeding

In order to reduce the amount of withdrawal bleeding, testosterone propionate (a male hormone preparation) can be injected at the same time as progesterone is injected intramuscularly, 25-50 mg per day for 3 days. If the amount of bleeding is still large, the patient should rest in bed and take general hemostatics such as vitamin K, hemostatics, vitamin C, and hemostatic aromatic acid orally or intramuscularly. In severe cases, glucose solution and blood transfusion can be used. Estrogen and progesterone preparations should not be used during withdrawal bleeding.

Tips: Medical curettage is suitable for unmarried patients with anovulatory functional uterine bleeding.